#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis acute Nephrotic syndrome Bronchiectasis Neuroblastoma Transitional cell cancer of the renal pelvis and ureter Krabbe's disease Paroxysmal nocturnal haemoglobinuria Hereditary angioedema Acute lymphocytic leukaemia Neurotrophic keratopathy Rheumatoid arthritis Progressive supranuclear palsy Aicardi-Goutieres syndrome Demyelination Advanced systemic mastocytosis More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia – Diagnostics Prader-Willi syndrome Marginal zone lymphoma refractory – Basic Information Chronic granulomatous disease – Trials in Disease Breast angiosarcoma – Life with Disease Brain stem glioma – Trials in Disease Phenylketonuria – Basic Information Glomerulonephritis membranoproliferative – Life with Disease Nephrotic syndrome – Basic Information Tuberous sclerosis complex – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Polydextrose Enfortumab Vedotin Omeprazole Bms-986408 Deferoxamine RO7795081 Ephedrine Hydrochloride Quercetin Bromocriptine Calcium Dexmedetomidine Hydrochloride Sodium Butyrate Olopatadine Avalotcagene Ontaparvovec Imifoplatin ANTI-GD2-800CW ZINC Telmisartan Mometasone Furoate Monohydrate Arginine Hydrochloride More therapies…

    Learn about Your Condition

    Pericarditis Type 1 diabetes mellitus Actinic cheilitis Non-obstructive cardiomyopathy Delayed graft function Polymyalgia rheumatica Fracture infection Bone marrow disorder Testis cancer Skin bacterial infection IgA nephropathy Plasma cell myeloma Coronary artery bypass Hypotonia Osteopenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on Graft-Versus-Host Disease Prevention Using Cyclophosphamide and Methotrexate in Adults with Blood Cancer Undergoing Matched-Donor Transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Graft versus host disease
    Investigated Drugs:
    • Anti-Human T-Lymphocyte Immunoglobulin From Rabbits
    • Clofarabine
    • Busulfan
    France

  • Study on CD19-CAR T Cells, Fludarabine, and Cyclophosphamide for Children and Young Adults with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    Investigated Drugs:
    • Cd19-Car_Lenti_Allo
    • Cyclophosphamide
    • Fludarabine Phosphate
    Italy

  • Study on the Safety and Effects of Karonudib for Patients with Advanced Leukemia, Lymphoma, and Multiple Myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Idarubicin Hydrochloride
    Denmark Sweden

  • Study on the Safety and Effectiveness of LIS1 for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)

    Recruiting

    1 1 1
    Investigated Diseases:
    • T-cell lymphoma
    Investigated Drugs:
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Pig
    France Italy

  • Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Carfilzomib
    • Bortezomib
    • Dexamethasone
    Belgium Croatia Czechia Denmark Finland France +10

  • Study of Azacitidine Treatment in Patients with VEXAS Syndrome

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • VEXAS syndrome
    Investigated Drugs:
    • Azacitidine
    Denmark Finland Norway Sweden
Previous Page
1 … 24 25 26 27 28 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!